A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

PHASE1UnknownINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

December 31, 2019

Conditions
Hypertension
Interventions
DRUG

CKD-320, D012

R: D012 1tablet, QD, PO T: CKD-320 2tablets, QD, PO

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY